Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
valsartan
Pharma
Pfizer is recalling five lots of a blood pressure drug in the US
After high levels of potential carcinogens forced multiple product pulls in Canada, Pfizer’s blood pressure recall has reached the U.S.
Fraiser Kansteiner
Apr 25, 2022 7:56am
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
Nov 19, 2021 8:20am
Valsartan recall protagonist comes off FDA warning letter
Nov 15, 2021 10:35am
Sanofi pulls hypertension meds in Korea, Canada and the U.K.
Aug 10, 2021 9:14am
Trade groups push FDA to refine carcinogen testing guidance
Jul 22, 2021 8:12am
Teva, Mylan must face fraud claims stemming from NDMA recalls
Feb 1, 2021 9:25am